This content is only available within our institutional offering.
27 Oct 2022
Q322 results and 15 questions for management
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Q322 results and 15 questions for management
- Published:
27 Oct 2022 -
Author:
Stent Jeff JS | Cross Gen GC | Ford Matthew MF -
Pages:
14 -
Summary of Q322 results
LFL sales, volumes and EBITDA were all modestly ahead of co. consensus expectations. To be more specific, LFL sales growth was +12.1% (co. cons: +10.2%) reflecting +3.7% volume growth (co. cons: +2.2%) and +8.0% rev/hl growth (co. cons: +7.8%). From a geographical perspective, South America was a particular standout with +27.0% LFL sales growth (co. cons: +20.2%) driven by pricing (+23.4%). EBITDA at USD5,313m was c.0.8% ahead of co. consensus and LFL EBITDA growth at +6.5% was +1.3% ahead of co. consensus.
News
We highlight that ABInBev is very enthused on the activation plans in place for the forthcoming first Southern Hemisphere summer FIFA world cup.
Earnings
We revise our FY22e by c.(1)%. Our FY23e and FY24e EPS are revised by (2)-(3)% as a consequence of both FX and an increase in estimated finance costs.
Investment thesis
ABInBev is inexpensive and is relatively underweight in Europe which is the region that we worry about most from a consumer trends perspective.
Rating and target price
We maintain our Outperform rating. Our target price moves from EUR61 to EUR60.
15 questions for management
You appeared somewhat more confident on this call than you have done over previous quarters, what is the basis for this?